Related Experiment Videos
Characterization of anti-BRCA2 antibodies in cell lines by Western blot analysis
D Bernard-Gallon1, L Cravello, C Vissac
1Laboratoire d'Oncologie Moleculaire, Centre Jean Perrin, 63011 Clermont-Ferrand Cedex 1, France.
Abstract:
BRCA2 is a tumor suppressor gene associated with familial predisposition to breast and ovarian cancer. BRCA2 has been implicated in response to DNA damage, cell cycle control and transcription. However, the mechanisms by which the BRCA2 protein suppresses tumor cell growth are largely unknown. To begin to understand the contribution of BRCA2 protein to tumorigenesis, we evaluated the specificity of 4 anti-BRCA2 antibodies directed against several different epitopes using immunoblotting techniques. The two monoclonal antibodies (3E6 and 5F6) detected a specific 384-kDa protein in human breast cancer cell lines (MCF7 and MDA-MB 231) and in a human colon carcinoma cell line (CCL 221). The two polyclonal antibodies (9433 and 9434) recognized the 384-kDa BRCA2 protein respectively in MCF7 and in CCL 221 cells, but both BRCA2 polyclonal antibodies also cross-reacted with smaller proteins.
Insights
Researchers evaluated four anti-BRCA2 antibodies to understand BRCA2
Area of Science:
- Molecular biology
- Cancer genetics
Background:
- BRCA2 is a tumor suppressor gene linked to hereditary breast and ovarian cancers.
- Its role in tumor suppression and mechanisms of action remain largely unelucidated.
- Understanding BRCA2's function is crucial for cancer research.
Purpose of the Study:
- To assess the specificity of four anti-BRCA2 antibodies.
- To aid in the characterization of the BRCA2 protein's role in tumorigenesis.
Main Methods:
- Immunoblotting techniques were employed.
- Four distinct anti-BRCA2 antibodies targeting different epitopes were utilized.
- Human breast and colon cancer cell lines were used for analysis.
Main Results:
- Two monoclonal antibodies (3E6, 5F6) specifically detected the 384-kDa BRCA2 protein in tested cell lines.
- Two polyclonal antibodies (9433, 9434) recognized the 384-kDa BRCA2 protein but also cross-reacted with smaller proteins.
- Antibody specificity varied, impacting reliable BRCA2 detection.
Conclusions:
- Monoclonal antibodies 3E6 and 5F6 demonstrate high specificity for the BRCA2 protein.
- Polyclonal antibodies showed cross-reactivity, potentially complicating results.
- These findings are essential for selecting appropriate tools in BRCA2 research.